101 related articles for article (PubMed ID: 23628949)
41. Cordyceps sinensis mycelium extract induces human premyelocytic leukemia cell apoptosis through mitochondrion pathway.
Zhang QX; Wu JY
Exp Biol Med (Maywood); 2007 Jan; 232(1):52-7. PubMed ID: 17202585
[TBL] [Abstract][Full Text] [Related]
42. Upregulation of Bcl-2 is associated with cisplatin-resistance via inhibition of Bax translocation in human bladder cancer cells.
Cho HJ; Kim JK; Kim KD; Yoon HK; Cho MY; Park YP; Jeon JH; Lee ES; Byun SS; Lim HM; Song EY; Lim JS; Yoon DY; Lee HG; Choe YK
Cancer Lett; 2006 Jun; 237(1):56-66. PubMed ID: 16009487
[TBL] [Abstract][Full Text] [Related]
43. Bcl-2 overexpression sensitizes MCF-7 cells to genistein by multiple mechanisms.
Tophkhane C; Yang S; Bales W; Archer L; Osunkoya A; Thor AD; Yang X
Int J Oncol; 2007 Oct; 31(4):867-74. PubMed ID: 17786319
[TBL] [Abstract][Full Text] [Related]
44. Mangiferin attenuates methylmercury induced cytotoxicity against IMR-32, human neuroblastoma cells by the inhibition of oxidative stress and free radical scavenging potential.
Das S; Nageshwar Rao B; Satish Rao BS
Chem Biol Interact; 2011 Sep; 193(2):129-40. PubMed ID: 21703249
[TBL] [Abstract][Full Text] [Related]
45. Formation of nuclear Bax/p53 complexes is associated with chemotherapy induced apoptosis.
Raffo AJ; Kim AL; Fine RL
Oncogene; 2000 Dec; 19(54):6216-28. PubMed ID: 11175336
[TBL] [Abstract][Full Text] [Related]
46. Induction of apoptosis by pectenotoxin-2 is mediated with the induction of DR4/DR5, Egr-1 and NAG-1, activation of caspases and modulation of the Bcl-2 family in p53-deficient Hep3B hepatocellular carcinoma cells.
Shin DY; Kim GY; Kim ND; Jung JH; Kim SK; Kang HS; Choi YH
Oncol Rep; 2008 Feb; 19(2):517-26. PubMed ID: 18202802
[TBL] [Abstract][Full Text] [Related]
47. A novel compound modified from tanshinone inhibits tumor growth in vivo via activation of the intrinsic apoptotic pathway.
Tian HL; Yu T; Xu NN; Feng C; Zhou LY; Luo HW; Chang DC; Le XF; Luo KQ
Cancer Lett; 2010 Nov; 297(1):18-30. PubMed ID: 20494511
[TBL] [Abstract][Full Text] [Related]
48. Dual apoptotic effect of Xrel3 c-Rel/NF-kappaB homolog in human cervical cancer cells.
Shehata M; Shehata M; Shehata F; Pater A
Cell Biol Int; 2004; 28(12):895-904. PubMed ID: 15566959
[TBL] [Abstract][Full Text] [Related]
49. In Vitro Assessment of Homeopathic Potencies of Hydrastis canadensis on Hormone-Dependent and Independent Breast Cancer.
Khan S; Nayak D; Khurana A; Manchanda RK; Tandon C; Tandon S
Homeopathy; 2020 Nov; 109(4):198-206. PubMed ID: 32610349
[TBL] [Abstract][Full Text] [Related]
50. Goldenseal (
Gao Y; Swiggart E; Wolkiewicz K; Liyanapathiranage P; Baysal-Gurel F; Avin FA; Lopez EFP; Jordan RT; Kellogg J; Burkhart EP
Molecules; 2024 Jan; 29(3):. PubMed ID: 38338301
[TBL] [Abstract][Full Text] [Related]
51. Goldenseal (Hydrastis canadensis L.) and its active constituents: A critical review of their efficacy and toxicological issues.
Mandal SK; Maji AK; Mishra SK; Ishfaq PM; Devkota HP; Silva AS; Das N
Pharmacol Res; 2020 Oct; 160():105085. PubMed ID: 32683037
[TBL] [Abstract][Full Text] [Related]
52. Chemical Evaluation of the Effects of Storage Conditions on the Botanical Goldenseal using Marker-based and Metabolomics Approaches.
Khin M; Cech NB; Kellogg JJ; Caesar LK
Yale J Biol Med; 2020 Jun; 93(2):265-275. PubMed ID: 32607087
[No Abstract] [Full Text] [Related]
53. Synergy-directed fractionation of botanical medicines: a case study with goldenseal (Hydrastis canadensis).
Junio HA; Sy-Cordero AA; Ettefagh KA; Burns JT; Micko KT; Graf TN; Richter SJ; Cannon RE; Oberlies NH; Cech NB
J Nat Prod; 2011 Jul; 74(7):1621-9. PubMed ID: 21661731
[TBL] [Abstract][Full Text] [Related]
54. Biochemometrics to Identify Synergists and Additives from Botanical Medicines: A Case Study with Hydrastis canadensis (Goldenseal).
Britton ER; Kellogg JJ; Kvalheim OM; Cech NB
J Nat Prod; 2018 Mar; 81(3):484-493. PubMed ID: 29091439
[TBL] [Abstract][Full Text] [Related]
55. In Silico Analysis of the Effect of
Vyshnavi Am H; Sankaran S; Namboori Pk K; Venkidasamy B; Hirad AH; Alarfaj AA; Vinayagam R
Medicina (Kaunas); 2023 Aug; 59(8):. PubMed ID: 37629702
[No Abstract] [Full Text] [Related]
56. Antimicrobial fungal endophytes from the botanical medicine goldenseal (
Egan JM; Kaur A; Raja HA; Kellogg JJ; Oberlies NH; Cech NB
Phytochem Lett; 2016 Sep; 17():219-225. PubMed ID: 28603575
[TBL] [Abstract][Full Text] [Related]
57. Effects of Hydrastis Canadensis, Commiphora Habessinica, Phytolacca Americana, and Echinacea Purpurea on Bacterial Growth.
Corn J; Tibbitts D; Ito H; Schafer M; Vasilevsky N
Altern Ther Health Med; 2021 Jul; 27(4):24-27. PubMed ID: 32619202
[TBL] [Abstract][Full Text] [Related]
58. Secondary Metabolites from the Leaves of the Medicinal Plant Goldenseal (
Leyte-Lugo M; Britton ER; Foil DH; Brown AR; Todd DA; Rivera-Chávez J; Oberlies NH; Cech NB
Phytochem Lett; 2017 Jun; 20():54-60. PubMed ID: 28736584
[TBL] [Abstract][Full Text] [Related]
59. Unlocking the Goldenseal Reveals the Complexities of Natural Product-Drug Interactions.
Embuldeniya S; Goralski KB
J Pharmacol Exp Ther; 2023 Dec; 387(3):249-251. PubMed ID: 37967895
[No Abstract] [Full Text] [Related]
60. [Note on the hydrastine content in cultivated Hydrastis canadensis L].
CABO TORRES J; TORROBA FOUCE P
Farmacognosia; 1951; 11(22):425-31. PubMed ID: 14954945
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
